Oblique Therapeutics

Developer of antibodies and small molecules for the treatment of advanced and metastatic cancer

placeGothenburg, Vastra Gotaland County, Sweden calendar_todayFounded 2015 groups23 employees language obliquet.com

Investor mix

4 investors on record; lead investors include Almi Invest, Sunstone.

Investor typeCountShare
Venture capital375%
Accelerator & incubator125%
Coming soon